Topical pimecrolimus does not prolong clear graft survival in a rat keratoplasty model

[1]  T. Reinhard,et al.  Systemische Immunsuppressiva nach perforierender Keratoplastik , 2007, Der Ophthalmologe.

[2]  T. Reinhard,et al.  Lokale Immunsuppressiva nach perforierender Keratoplastik , 2007, Der Ophthalmologe.

[3]  T. Reinhard,et al.  Immunsuppression nach perforierender Keratoplastik , 2007, Der Ophthalmologe.

[4]  T. Reinhard,et al.  [Systemic immunosuppressives after penetrating keratoplasty]. , 2007, Der Ophthalmologe.

[5]  T. Reinhard,et al.  [Immune suppression following perforating keratoplasty]. , 2007, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[6]  T. Reinhard,et al.  [Topical immunosuppressives after penetrating keratoplasty]. , 2007, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[7]  P. Gisondi,et al.  Pimecrolimus in dermatology: atopic dermatitis and beyond , 2005, International journal of clinical practice.

[8]  D. Böhringer,et al.  Immunosuppression with Cyclosporine A and Mycophenolate Mofetil After Penetrating High-Risk Keratoplasty: A Retrospective Study , 2005, Transplantation.

[9]  T. Reinhard,et al.  Topical FK506 as immunoprophylaxis after allogeneic penetrating normal‐risk keratoplasty: a randomized clinical pilot study , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  A. Gottlieb,et al.  A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis , 2005, The Journal of dermatological treatment.

[11]  A. Billich,et al.  The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study. , 2005, Veterinary ophthalmology.

[12]  F. Claas,et al.  FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations , 2004, British Journal of Ophthalmology.

[13]  T. Reinhard,et al.  Lokales Fk506 bei entzündlichen Erkrankungen von Hornhaut und Bindehaut: Eine Pilotstudie , 2002 .

[14]  T. Reinhard,et al.  [Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study]. , 2002, Klinische Monatsblatter fur Augenheilkunde.

[15]  E. Godehardt,et al.  COADMINISTRATION OF THE NEW MACROLIDE IMMUNOSUPPRESSANT RAD AND MYCOPHENOLATE MOFETIL IN EXPERIMENTAL CORNEAL TRANSPLANTATION , 2000, Transplantation.

[16]  E. Godehardt,et al.  Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model , 1998, The British journal of ophthalmology.

[17]  M. Mochizuki,et al.  Use of topical FK506 in a corneal graft rejection model in Lewis rats. , 1997, Investigative ophthalmology & visual science.

[18]  M. Nishi,et al.  Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection. , 1989, Japanese journal of ophthalmology.

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .